The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine
Abstract
Sixty-seven subjects, including normal volunteers and patients with obsessive-compulsive disorder, social phobia, and borderline personality disorder, received ratings of depersonalization after double-blind, placebo-controlled challenges with the partial serotonin agonist meta-chlorophenylpiperazine (m-CPP). Challenge with m-CPP induced depersonalization significantly more than did placebo. Subjects who became depersonalized did not differ in age, sex, or diagnosis from those who did not experience depersonalization. There was a significant correlation between the induction of depersonalization and increase in panic, but not nervousness, anxiety, sadness, depression, or drowsiness. This report suggests that serotonergic dysregulation may in part underlie depersonalization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental partial agonism at serotonin 5-HT2A and 5-HT2C receptors induced a broad array of dissociative symptoms in individuals with social phobia, borderline personality disorder, and obsessive-compulsive disorder [125].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [125]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Measurement of lactate-induced panic and anxiety
Dillon, D. J., Gorman, J. M., Liebowitz, M. R., Fyer, A. J., & Klein, D. F. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90002-3 · Cited by 221
The Phobic Anxiety-depersonalization Syndrome [Abridged]
Roth, M. (1959) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591575905200802 · Cited by 162
The Depersonalization Syndrome
Shorvon, H. J. (1946) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591574603901206 · Cited by 114
Depersonalization Phenomena in Psychiatric Patients
Brauer, R., Harrow, M., & TUCKER, G. J. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.117.540.509 · Cited by 97
THE PHOBIC ANXIETY–DEPERSONALIZATION SYNDROME
James, I. P. (1961) · American Journal of Psychiatry · doi:10.1176/ajp.118.2.163 · Cited by 89
Depersonalization after marijuana smoking
Mathew, R. J., Wilson, W. H., Humphreys, D. F., Lowe, J. V., & Weithe, K. E. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90171-9 · Cited by 70
Left hemispheric activation in depersonalization disorder: A case report
Hollander, E., Carrasco, J. L., Mullen, L. S., Trungold, S., DeCaria, C. M., & Towey, J. P. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90161-r · Cited by 55
Self-citationTreatment of depersonalization with serotonin reuptake blockers.
Hollander, E., Liebowitz, M. R., DeCaria, C. M., FAIRBANKS, J., Fallon, B. A., & Klein, D. F. (1990) · PubMed · Cited by 53
Self-citationReview of the relationship between obsession and depersonalization
Torch, E. M. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06931.x · Cited by 48
Cited by
Feeling Unreal: A PET Study of Depersonalization Disorder
Simeon, D., Guralnik, O., Hazlett, E. A., Spiegel-Cohen, J., Hollander, E., & Buchsbaum, M. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1782 · Cited by 320
Self-citationDepersonalisation Disorder: A Contemporary Overview
Simeon, D. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00002 · Cited by 198
Self-citationFeeling unreal: 30 cases of DSM-III-R depersonalization disorder
Simeon, D., Gross, S., Guralnik, O., Stein, D. J., Schmeidler, J., & Hollander, E. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1107 · Cited by 140
Self-citationBrand, B. L., Lanius, R. A., Vermetten, E. H. G. J. M., Loewenstein, R. J., & Spiegel, D. (2012) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2011.620687 · Cited by 134
“In terms of pharamacotherapeutic interventions for dissociative symptoms, research using selective serotonin reuptake inhibitors in individuals with depersonalization disorder (DPD) has shown that serotonin agonists such as meta-chlorophenylpiperazine can induce symptoms of depersonalization ( Simeon, Hollander, et al…”
BackgroundDissociation in the laboratory: a comparison of strategies
Leonard, K. N., Telch, M. J., & Harrington, P. J. (1999) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(98)00072-2 · Cited by 109
“Based on observations linking serotonergic dysfunction and dissociation, Simeon et al. (1995) administered the serotonin agonist, chlorophenylipiperazine (m-CPP) to 67 normal and patient volunteers.”
Background
Metadata
- Authors
- Simeon, D., Hollander, E., Stein, D. J., DeCaria, C., Cohen, L. J., Saoud, J. B., Islam, N., & Hwang, M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Stellenbosch University (ZA)
- Corresponding author
- Simeon, Daphne
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 1995-09
- Volume
- 58
- Issue
- 2
- Pages
- 161-164
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W2001268486
- Cited by
- 41
- References
- 15
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2017: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1k01mh000750-01)
- National Institute of Mental Health (MH00750)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- depersonalization, mCPP, serotonin receptor agonists, obsessive-compulsive disorder, social anxiety disorder, borderline personality disorder, panic
- MeSH terms
- Adult, Animals, Arousal, Borderline Personality Disorder, Brain, Depersonalization, Double-Blind Method, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Panic, Phobic Disorders, Piperazines, Reality Testing, Serotonin, Serotonin Receptor Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. https://app.cochat.ai/papers/10.1016/0165-1781(95)02538-8
- The paper
- Simeon, D., Hollander, E., Stein, D. J., DeCaria, C., Cohen, L. J., Saoud, J. B., Islam, N., & Hwang, M. (1995). Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Research. https://doi.org/10.1016/0165-1781(95)02538-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.